News
B Verve Therapeutics (VERV) acquisition offers investors a 70%+ premium. See why I think this deal is beneficial to both ...
Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular ...
CNBC’s Angelica Peebles reports on the latest news surrounding Eli Lilly. Canadian Indigenous leader says he was 'filled with ...
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...
NEW YORK — (AP) — U.S. stock indexes are drifting lower on Tuesday, while oil prices rise again.
According to Berenberg’s analysis, last year Novo Nordisk and Eli Lilly generated a RORI of 26 per cent and 24 per cent, ...
Explore more
The deal centers around a medicine that could “shift the treatment paradigm for cardiovascular disease,” Lilly said, but also ...
Yum Brands named Chief Financial Officer Chris Turner as its next chief executive. Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion Deal would add a potential treatment for ...
US Stocks Market fall as weak US retail sales, housing, and industrial data add to fears of a slowdown, while Middle East ...
Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular diseaseLilly's established capabilities ...
The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results